NCT05242016

Brief Summary

Palliative Care is the care offered by a simultaneous multidisciplinary approach with all treatments aimed at preventing/alleviating suffering and increasing the quality of life by early identifying all physical, psycho-social and spiritual needs, especially pain, to individuals and their families who face problems arising from life-threatening diseases. philosophy. For this reason, it includes the quality of life and the positive effect of the disease process. Symptom management starts from the moment of diagnosis and lasts until the moment of death, and as in all areas, complementary therapies are very important in palliative care as well as pharmacological treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 4, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 16, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2023

Completed
Last Updated

May 26, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

January 2, 2022

Last Update Submit

May 24, 2023

Conditions

Keywords

self-transcendencestructured reminiscencelife satisfactionsymptom managementpalliative carewell-being

Outcome Measures

Primary Outcomes (2)

  • self-transcendence scale

    The change in self-transcendence scores of the patients in the structured individual reminiscence group after the application compared to the pre-application. The self-transcendence scale score ranges from 15 to 60, and an increase in scores indicates that the individual is self-actualizing.

    15 days

  • life satisfaction

    The change life satisfaction in scores of the patients in the structured individual reminiscence group after the application compared to the pre-application. The life satisfaction scale score ranges from 5-35, and an increase in the score indicates that the individual's life satisfaction is high.

    15 days

Study Arms (3)

structured individual reminiscence

EXPERIMENTAL

Sessions, in chronological order; Starting with birth, it is planned to progress through life years by focusing on important events. In the sessions, considering the age and individual characteristics of the patients, the house and region where they were born and raised, childhood and school memories, childhood and school friends, youth years and friends, business life, if any, marriage process, birth of the first child, happy memories about children, successful events, old holidays It is talked about subjects such as unforgettable people or events, happy places to visit, old meals, old items, old songs. In each session, different sensory stimuli (visual, auditory, tactile, smelling, tasting) are used according to the subject.

Other: structured individual reminiscence

unstructured social interview

PLACEBO COMPARATOR

Unstructured social interviews are conducted on topics such as current events not related to recollection, information specific to the individual patient wants to share, illness/diseases, hobbies, and activities.

Other: unstructured social interview

Control

NO INTERVENTION

There is no intervention other than standard nursing care.

Interventions

reminiscence therapy

structured individual reminiscence

placebo

unstructured social interview

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Speaking and understanding Turkish
  • Those who volunteered to participate in the research
  • Inpatient in Palliative Care Service
  • Without clinical diagnosis of dementia, cognitive impairment, agitation and delirium
  • No hearing or vision problems

You may not qualify if:

  • Patients who are planned to be transferred and/or discharged to another unit/institution within the estimated period of investigation (15 days) by the physician and who do not have a life expectancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bandirma Training and Research Hospital

Bandırma, Balikesi̇r, 10200, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Bozkurt C, Yildirim Y. The effectiveness of reminiscence therapy on the symptom management, the life satisfaction, and the self-transcendence in palliative care patients: a randomized controlled trial. Support Care Cancer. 2024 Jun 14;32(7):431. doi: 10.1007/s00520-024-08626-9.

MeSH Terms

Conditions

Personal Satisfaction

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Questionnaires are administered to three groups: structured individual reminiscence, unstructured social interview, and control, before the application (day 1) and after the application (day 15).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

January 2, 2022

First Posted

February 16, 2022

Study Start

November 4, 2021

Primary Completion

March 31, 2022

Study Completion

May 25, 2023

Last Updated

May 26, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations